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Abstract
Aims/hypothesis Glucokinase (GCK) plays a role in glucose
metabolism and glucose-stimulated insulin secretion. Rare
mutations in GCK cause MODY. We investigated
whether common variation (minor allele frequency
≥0.01) in GCK is associated with metabolic traits and
type 2 diabetes.
Methods Four exonic single-nucleotide polymorphisms
(SNPs) and three SNPs predicted to cause loss of promoter
function were identified in whole-genome sequence data from
234 Pima Indians. These seven tag SNPs and rs4607517, a
type 2 diabetes variant established in other studies, were
analysed in 415 full-heritage non-diabetic Pima Indians
characterised for metabolic traits, and 7,667 American Indians
who had data on type 2 diabetes and BMI.
Results A novel 3′ untranslated region (3′UTR) SNP,
chr7:44184184-G/A, was associated with the rate of carbohy-
drate oxidation post-absorptively (β=0.22 mg [kg estimated
metabolic body size (EMBS)]−1min−1, p=0.005) and during a
hyperinsulinaemic–euglycaemic clamp (β=0.24 mg [kg
EMBS]−1min−1, p=0.0002), the rate of carbohydrate oxidation
in a respiratory chamber (β=311 kJ/day, p=0.03) and 24 h
energy expenditure, which was attributable to the thermic effect
of food (β=520 kJ/day, p=3.39×10−6). This 3′UTR SNP was
also associated with diabetes (OR 1.36, 95% CI 1.11, 1.65,
p=0.002), where the A allele (allele frequency 0.05) was asso-
ciated with a lower rate of carbohydrate oxidation, lower 24 h
energy expenditure and higher risk for diabetes. In a Cox
proportional hazards model, a rate of insulin-stimulated carbo-
hydrate oxidation lower than themean rate at baseline predicted
a higher risk for developing diabetes than for those above the
mean (hazard rate ratio 2.2, 95% CI 1.3, 3.6, p=0.002).
Conclusions/interpretation Common variation in GCK influ-
ences the rate of carbohydrate oxidation, 24 h energy expen-
diture and diabetes risk in Pima Indians.
Keywords Carbohydrate oxidation . Energy expenditure .
GCK . Thermic effect of food . Type 2 diabetes
Abbreviations
3′UTR 3′ Untranslated region
AIR Acute insulin response
BAT Brown adipose tissue
EMBS Estimated metabolic body size
G6P Glucose-6-phosphate
GCK Glucokinase
GEE Generalised estimating equation
HRR Hazard rate ratio
mAF Minor allele frequency
LD Linkage disequilibrium
NGT Normal glucose tolerance
RQ Respiratory quotient
SNP Single-nucleotide polymorphism
SPA Spontaneous physical activity
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Glucokinase (GCK) is a hexokinase isozyme (hexokinase IV)
that catalyses glucose to glucose-6-phosphate (G6P) and is
involved in the first step of both glycolysis and glycogen
synthesis. GCK is predominantly expressed in hepatocytes
and pancreatic beta cells, with isoforms distinct in the N
terminus. The pancreatic beta cell isoform is a key enzyme
in regulating glucose-stimulated insulin secretion and is con-
sidered to be a glucose sensor. The liver isoform plays a
central role in regulating glucose homeostasis and is a major
component of the hepatic glucose-sensing system involved in
glucose synthesis, breakdown and storage [1–3]. Rare hetero-
zygous inactivating mutations in GCK cause MODY, mainly
due to a reduced glucose-stimulated insulin secretion [4].
While rare mutations inGCK cause MODY, common variants
have been associated with HbA1c levels, fasting glucose con-
centrations and type 2 diabetes in white and other populations
[5–7]. No rare coding variants in GCK were identified in 234
Pima Indians with whole-genome sequence data (unpublished
data, Y. L. Muller). Thus, in the current study, we investigated
the effects of common and low-frequency GCK variants with
a minor allele frequency (mAF) ≥0.01 on metabolic traits and
type 2 diabetes risk in Pima Indians.
Methods
Participants with outpatient longitudinal data on type 2 diabetes
and BMI Electronic supplementary material (ESM) Fig. 1
shows a flow chart depicting the study design and selection
of participants. All individuals in this study are participants of
a longitudinal study of the aetiology of type 2 diabetes among
the Gila River Indian Community in Arizona, where most of
the residents are Pima Indians or Tohono O’odham (a closely
related tribe) [8]. Diabetes was determined by prior clinical
diagnosis or an oral glucose tolerance test according to the
criteria of the American Diabetes Association [9]. A
population-based sample of full-heritage Pima Indians
(n=3,604, including 736 sibships [sibship is defined as sibs
≥2], Table 1) was initially used to assess associations with type
2 diabetes. A non-overlapping sample of mixed-heritage
American Indians from the same longitudinal study
(n=4,063, including 739 sibships; reported heritage, on aver-
age, was one-half Pima and three-quarters American Indian,
Table 1) was used to assess replication. Among these samples,
BMI was measured at biennial examinations and maximum
BMI observed in the longitudinal study was analysed in 3,391
full-heritage Pima Indians and 3,406 mixed-heritage American
Indians (Table 1) who were examined when aged ≥15 years.
Fasting serum glucose concentrations were measured in 2,542
full-heritage Pima Indians and 2,887 mixed-heritage American
Indians that were non-diabetic, including individuals who
subsequently developed diabetes and those who remained
non-diabetic (Table 1).
Subset of participants with additional inpatient data on quan-
tifiable metabolic traits Among the full-heritage Pima Indians
described above, 415 non-diabetic individuals (including 99
sibships; male sex 58%, age 27±6 years and BMI 34±8 kg/m2
at the time of metabolic testing) had undergone detailed stud-
ies of metabolic and anthropometric phenotypes for risk fac-
tors related to type 2 diabetes and obesity. Body composition,
including percentage body fat, fat mass and fat-free mass, was
estimated by underwater weighing until 1996 and by dual
energy x-ray absorptiometry (DPX-1; Lunar Radiation Corp.,
Madison, WI, USA ) thereafter [10]. Glucose tolerance was
determined by a 75 g OGTT, with measurements of fasting,
30, 60, 120 and 180 min plasma glucose and insulin concen-
trations [11]. A hyperinsulinaemic–euglycaemic clamp (insu-
lin infusion rate of 40 mU m−2 min−1 with simultaneous
glucose tracers) was used to measure rates of post-absorptive
(basal) and insulin-stimulated glucose disappearance as pre-
viously described [11]. Indirect calorimetry measurements
using a ventilated hood system were performed before and
during the insulin infusion to assess rates of energy expendi-
ture and substrate oxidation [12, 13]. Pancreatic beta cell
function was assessed by the acute insulin response (AIR)
after a 25 g intravenous glucose bolus and calculated as the
mean increment in plasma insulin concentrations from 3 to
5 min [11].
To measure 24 h energy expenditure, study participants
entered a respiratory chamber for 23 h and 15 min after an
overnight fast and after at least 3 days of a weight-maintaining
diet [14]. Four meals were provided at 08:00, 11:00, 16:00 and
19:00 hours. Fresh air was drawn through the chamber, and
CO2 production and O2 consumption were measured and
calculated every 15 min and extrapolated to the 24 h period
[15]. Spontaneous physical activity (SPA) was detected by
radar sensors and expressed as percentage of time in motion
per 15 min interval. The energy cost of SPAwas calculated as
the product of average SPA over 24 h and the slope of the
regression line between energy expenditure and SPA between
08:00 and 23:00 hours [15]. Sleeping metabolic rate was
defined as the average energy expenditure of all 15 min pe-
riods between 1:00 and 5:00 hours during which SPA was
<1.5%, and was extrapolated to 24 h [16]. The 24 h respiratory





O2 . Carbohydrate and lipid oxidation rates were
derived from the 24 h RQ after accounting for protein oxida-
tion, which was estimated from the 24 h urinary nitrogen
excretion [15].
Identification and genotyping of single-nucleotide
polymorphisms Single-nucleotide polymorphisms (SNPs) in
exons and the putative promoter region (∼1.4 kb upstream of
Diabetologia (2014) 57:1382–1390 1383
the translational start site) ofGCKwere obtained from whole-
genome sequence data (30–40× coverage) of 234 individuals
who were predominantly full-heritage Pima Indians (Com-
plete Genomics, Mountain View, CA, USA; Illumina, San
Diego, CA, USA). Individuals had been characterised for
metabolic traits in our Clinical Research Center and were
selected from different nuclear families to maximise identifi-
cation of genetic variation. Genome sequence data were com-
pared with the reference sequence GRCh37/hg19. SNPs not
reported in NCBI dbSNP/1000 genomes (http://www.ncbi.
nlm.nih.gov/SNP/; or http://browser.1000genomes.org/)
were classified as ‘novel’. Linkage disequilibrium (LD) was
determined using Haploview (version 4.2, Broad Institute,
Cambridge, MA, USA). Tag SNPs were selected using the
Tagger algorithm with a pairwise r2≥0.8 taken as indicative of
redundancy.
SNPs were genotyped for association analyses using the
TaqMan Allelic Discrimination Assay on an ABI Prism 7900
(Applied Biosystems, Carlsbad, CA, USA) or BeadXpress
System (Illumina).
Allelic specific gene expression Total RNAwas isolated from
percutaneous abdominal adipose tissue biopsies from 14 in-
dividuals who were heterozygous for the 3′ untranslated
region (3′UTR) SNP chr7:44184184-G/A. RNA was
reverse-transcribed to cDNA and allelic specific expression
was performed on an ABI Prism 7900 using a TaqMan probe
(Applied Biosystems). The ratio of allele G/A expression was
normalised to the genomic DNA control.
Statistical analyses Statistical analyses were performed using
the software of the SAS Institute (version 9.2, Cary, NC,
USA). A logistic regression analysis was used to assess the
association of genotypes with type 2 diabetes and was adjust-
ed for age, sex, birth year and heritage as covariates. The
model was fit with the generalised estimating equation
(GEE) to account for dependence among siblings. Genotype
was analysed as a numeric variable representing 0, 1 or 2
copies of a given allele. To estimate the proportion of Euro-
pean ancestry, 45 informative markers with large differences
in allele frequency between populations [17] were used as a
covariate in these analyses. The association of quantifiable
traits with genotypes was analysed by linear regression using
the GEE procedure to account for correlation among siblings.
Results were adjusted for covariates as indicated. The rate of
carbohydrate oxidation, as a metabolic predictor of diabetes,
was assessed in individuals with normal glucose tolerance
(NGT) who had measures of carbohydrate oxidation rate at
baseline during a hyperinsulinaemic–euglycaemic clamp.
These individuals also had biennial follow-up OGTTs to
determine diabetes status. The Cox proportional hazards mod-
el was used to determine the hazard rate ratio (HRR) for
developing type 2 diabetes associated with the rate of
insulin-stimulated carbohydrate oxidation including age, sex,
percentage body fat, AIR and non-oxidative glucose disposal
rate as covariates. Follow-up time was defined as the time
from the measure of carbohydrate oxidation rate during an
insulin clamp to either type 2 diabetes onset or the last eval-
uation when an individual remained non-diabetic. To analyse
the effect of genotype on the energy expenditure trajectory, a
mixed model analysis was used including time, time2 and
time3 as fixed effects to model the non-linearity of the trajec-
tory. Results were adjusted for age, sex, fat mass, fat-free mass
and SPA.
Results
Association of GCK SNPs with carbohydrate oxidation
rate Whole-genome sequence data from 234 Pima Indians
were used to identify common SNPs (mAF≥0.01). Five SNPs
were identified in exon regions: two synonymous amino acid
substitutions, GCK-G193G and GCK-Y215Y (rs144723656),
Table 1 Characteristics of full-
heritage Pima Indians and mixed-
heritage American Indians
analysed in the population-based
association studies
Age and BMI data are shown as
means ± SD
Characteristic n Male sex (%) Age (years) BMI (kg/m2)
Full-heritage Pima Indians
Type 2 diabetes study 3,604
Diabetic (46%) 1,658 37 49.1±14.1 38.7±8.6
Non-diabetic 1,946 48 32.1±14.6 36.1±8.5
BMI study 3,391 42 36.1±13.3 37.4±8.7
Fasting glucose concentration study 2,542 43 39.0±14.5 35.7±8.3
Mixed-heritage American Indians
Type 2 diabetes study 4,063
Diabetic (21%) 853 41 41.1±14.2 38.7±8.7
Non-diabetic 3,210 47 24.9±11.9 33.5±8.4
BMI study 3,406 45 29.2±12.0 34.8±8.8
Fasting glucose concentration study 2,887 44 30.4±12.3 33.5±8.3
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and three 3′-UTR SNPs, rs13306388, rs55714218 and a novel
SNP chr7:44184184-G/A. Four SNPs were identified in the
putative promoter region and were predicted to cause loss of
function by the Ingenuity Variant Analysis (https://variants.
ingenuity.com): rs1799831, rs1799884, rs193226243 and
rs1476891. These nine SNPs and rs4607517 (which has
been associated with type 2 diabetes in other studies [5–7]
and maps 6.6 kb upstream of GCK) were analysed for
pairwise LD. Eight tag SNPs capture all ten SNPs (r2≥0.8,
ESM Fig. 2).
These eight tag SNPs (mAF≥0.01) were genotyped in a
population-based sample of 3,604 full-heritage Pima Indians
of which 415 non-diabetic individuals had detailed measures
of metabolic and anthropometric phenotypes for risk factors
related to type 2 diabetes and obesity. Associations of these
eight tag SNPs with metabolic traits were analysed in these
415 individuals. For the novel 3′UTR SNP chr7:44184184-G/
A (mAF 0.05), only two of the 415 individuals were homo-
zygous for the minor A allele, so their data were combined
with those of the G/A heterozygotes for statistical analyses.
Individuals with the A allele had a lower mean rate of basal
carbohydrate oxidation (Fig. 1, β=0.22 mg [kg estimated
metabolic body size (EMBS)]−1min−1 per risk allele, p=
0.005, adjusted for age, sex and percentage body fat) and
lower rate of insulin-stimulated carbohydrate oxidation (β=
0.24 mg [kg EMBS]−1min−1, adjusted p=0.0002) when com-
pared with individuals with the G allele. However, the non-
oxidative glucose disposal rate at baseline and during insulin
stimulation was not different between the two groups (adjusted
p=0.18 at basal state, p=0.92 during insulin stimulation).
Furthermore, individuals with the A allele had a higher lipid
oxidation rate at baseline by 0.08 mg [kg EMBS]−1min−1
(Table 2, p=0.007, adjusted for age, sex and percentage body
fat) and during insulin infusion by 0.09 mg [kg EMBS]−1min−1
(adjusted p=0.01) when compared with individuals with the G
allele. These changes in lipid oxidation rate may be second-
ary to the changes in carbohydrate oxidation rate. Individuals
with the A allele also had a lower basal rate of endogenous
glucose production (β=0.08 mg [kg EMBS]−1 min−1, adjust-
ed p=0.03), but no difference in endogenous glucose pro-
duction rate during insulin infusion (adjusted p=0.31). This
3′UTR SNP was not associated with the whole-body insulin-
stimulated glucose disposal rate (adjusted p=0.19). The rest-
ing metabolic rate also did not differ (p=0.94, adjusted for
age, sex, fat mass and fat-free mass) between those with the
A allele and those with the G allele.
Association of GCK SNPs with 24 h energy expenditure In the
respiratory chamber study, participants with the A allele for
the 3′UTR SNP chr7:44184184-G/A had a lower 24 h energy
expenditure (by 520 kJ/day) than those with the G allele (as
the difference in least square means); this was more evident in
the postprandial state, as shown by the energy expenditure
trajectory over the day (Fig. 2a).
Three components of 24 h energy expenditure, including the
sleeping metabolic rate (60–70% of total energy expenditure),
energy cost of SPA (20–30%) and thermic effect of food (awake
and fed thermogenesis, 10%) were described previously [15,
18]. The difference in 24 h energy expenditure between geno-
types of the 3′UTR SNP is attributable to the difference in the
thermic effect of food (Fig. 2b, β=520 kJ/day, p=3.39×10−6
for 24 h energy expenditure, adjusted for age, sex, fat mass, fat-
free mass and SPA), but not to SPA (p=0.16, adjusted for age
and sex) or sleeping metabolic rate (adjusted for age, sex, fat
mass and fat-free mass, p=0.27). To confirm this observation,
we further analysed the effects of genotype on the energy
expenditure trajectory during the postprandial state (daytime)
vs fasting state (night-time) using amixedmodel analysis. After
accounting for age, sex, fat mass, fat-free mass and SPA,
individuals with the A allele had a lower rate of energy expen-
diture during the day (β=−0.46 kJ/min, p=0.0001, from
8:00 hours on one day to 01:00 hours on the next day),
compared with those with the G allele, but no difference was
observed during the night (β=−0.07 kJ/min, p=0.50, from
01:00 hours to 05:00 hours). This result demonstrates that the
difference in 24 h energy expenditure between genotypes is
driven by the thermic effect of food in the postprandial state.
In the chamber, individuals with the A allele also had a
decreased rate of carbohydrate oxidation (by 311 kJ/day)
compared with those with the G allele (Fig. 2c, p=0.03,
adjusted for age, sex, percentage body fat and energy balance).
This was comparable with the difference in the rate of carbo-
hydrate oxidation during a hyperinsulinaemic–euglycaemic
clamp, in which a ∼70 kg (EMBS) individual with the A allele
was estimated to have a lower rate of insulin-stimulated car-
bohydrate oxidation (by ∼406 kJ/day). However, neither the
















































Fig. 1 Oxidative and non-oxidative glucose disposal rates post-
absorptively and during insulin infusion at 40 mU m−2 min−1 based on
genotypes for the 3′UTR SNP chr7:44184184-G/A. Black bar, oxidative
glucose disposal rate; white bar, non-oxidative glucose disposal rate.
Error bar: SD. *p<0.05; **p<0.01; ***p<0.001
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genotypes (p=0.61 and p=0.53, respectively, adjusted for age,
sex, percentage body fat and energy balance), indicating that
the 3′UTR SNP affected energy expenditure primarily via
carbohydrate oxidation.
All eight tag SNPs were analysed for associations with
metabolic traits in 415 full-heritage non-diabetic individuals
(data not shown). Only the 3′UTR SNP was associated with
the rate of carbohydrate oxidation and 24 h energy expendi-
ture (Figs 1 and 2, Table 2).
Association of GCK SNPs with type 2 diabetes and BMI The
eight tag SNPs were genotyped in a population-based sample
of 3,604 full-heritage Pima Indians and a replication sample of
4,063 mixed-heritage American Indians for association anal-
yses of type 2 diabetes and BMI. The 3′UTR SNP
chr7:44184184-G/A had a nominal association with type 2
diabetes in full-heritage Pima Indians (Table 3; OR 1.37, 95%
CI 1.06, 1.78, p=0.015, adjusted for age, sex, birth year and
heritage). This SNP also had a borderline association with
Table 2 Metabolic characteristics of non-diabetic full-heritage individuals by genotypes of the 3′UTR SNP chr7:44184184-G/A
Characteristic chr7:44184184 (mean ± SD) p valuea
G/G G/A + AA Estimate
Participants (n) 369 33
Body fat (%) 32.9±8.6 34.0±7.9 −0.82 0.54
Oral glucose tolerance test
Fasting plasma glucose (mmol/l) 4.4±0.5 5.0±0.8 −0.05 0.68
2 h plasma glucose (mmol/l) 6.9±1.7 6.9±1.8 −0.15 0.56
Log10 fasting plasma insulin (pmol/l) 3.0±1.1 3.0±1.1 0.87 0.67
Log10 2 h plasma insulin (pmol/l) 2.4±1.0 2.4±1.0 0.86 0.93
Hyperinsulinaemic– euglycaemic clamp (mg [kg EMBS]−1min−1)b
Log10 glucose disposal rate 0.55±0.1 0.51±0.1 0.02 0.19
Carbohydrate oxidation 2.10±0.5 1.76±0.5 0.24 0.0002
Lipid oxidation 0.41±0.3 0.55±0.3 −0.09 0.01
Endogenous glucose output 0.38±0.4 0.33±0.3 0.05 0.31
Basal glucose output (mg [kg EMBS]−1min−1) 1.91±0.2 1.83±0.2 0.08 0.03
Basal carbohydrate oxidation (mg [kg EMBS]−1min−1) 1.42±0.4 1.20±0.5 0.22 0.005
Basal lipid oxidation (mg [kg EMBS]−1min−1) 0.71±0.3 0.80±0.2 −0.08 0.007
Resting metabolic rate (kJ/day) 7,314±1,298 7,574±1,583 −8.08 0.94
Participants, NGT (n) 268 23
Log10 AIR (pmol/l) 3.2±1.1 3.2±1.2 0.91 0.46
Log10 30-min plasma insulin (pmol/l) 3.2±1.1 3.2±1.1 0.89 0.43
Participants in metabolic chamber study (n) 277 23
Body fat (%) 33.2±8.2 33.9±7.6 0.08 0.99
24 h RQ 0.85±0.02 0.85±0.02 0.004 0.53
Carbohydrate oxidation (kJ/day) 4,589±988 4,363±959 311 0.03
Lipid oxidation (kJ/day) 4,007±1,269 3,866±1,034 134 0.61
Protein oxidation (kJ/day) 1,231±536 1,281±477 −60 0.53
24 h energy expenditure (kJ/day) 9,927±1,700 9,734±1,486 520 3.39×10−6
Sleeping metabolic rate (kJ/day) 7,046±1,214 7,138±1,017 136 0.27
Energy cost of SPA (kJ/day) 1,562±565 1,206±494 164 0.16
Values for mean ± SDwere unadjusted. The effect size estimates were calculated as the differences in least square means andwere adjusted for covariates
Rate of glucose disappearance during insulin stimulation, fasting, 30 min and 2 h plasma insulin concentrations and AIR were log10-transformed before
analyses to approximate a normal distribution
a The p value for percentage body fat was adjusted for age and sex. The p value for AIR was adjusted for age, sex, percentage body fat and rate of glucose
disappearance during insulin stimulation. The p values for resting metabolic rate and sleeping metabolic rate were adjusted for age, sex, fat mass and fat-
free mass. The p value for 24 h energy expenditure was adjusted for age, sex, fat mass, fat-free mass and SPA. The p values for 24 h RQ and
macronutrient oxidation were adjusted for age, sex, percentage body fat and energy balance. All remaining p values were adjusted for age, sex and
percentage body fat
b EMBS is equivalent to fat-free mass +17.7 kg
1386 Diabetologia (2014) 57:1382–1390
type 2 diabetes in a replication sample of mixed-heritage
American Indians (OR 1.32, 95% CI 0.97, 1.79, adjusted p=
0.075). A lower p value was observed in a combined analysis
of all individuals (OR 1.36, 95% CI 1.11, 1.65, adjusted p=
0.002, n=7,667). Due to the low allele frequency (mAF 0.05),
hence limited statistical power, this SNP only achieved a type
2 diabetes association at p=0.002 despite a considerable effect
size (OR 1.36). The A allele, associated with a lower rate of
carbohydrate oxidation rate and 24 h energy expenditure, was
associated with a higher prevalence of type 2 diabetes. In
addition, the promoter SNP rs1476891 (D′=0.88, r2=0 with
the 3′UTR SNP, ESM Fig. 2) had a nominal association with
type 2 diabetes in a combined analysis (OR 1.15, 95% CI
1.02, 1.31, adjusted p=0.03).
SNP rs4607517, which was reproducibly associated with
fasting glucose concentrations in other populations [5–7], also
had strong associations with fasting glucose concentrations in
a combined analysis of 5,429 American Indians (β=
0.06 mmol/l per risk allele, p=8.7×10−7, adjusted for age,
sex, birth year and heritage) (Table 3). However, this SNP was
not associated with type 2 diabetes (adjusted p=0.16, n=
7,667). In addition, the synonymous SNP Gly193Gly and
rs193226243 were also associated with fasting glucose con-
centrations (β=0.25 mmol/l, adjusted p=4.3×10−5; β=
0.08 mmol/l, adjusted p=0.0003, respectively).
Beta cell function was assessed by AIR in 298 full-heritage
Pima Indians with NGT. SNP rs4607517, associated with
fasting glucose concentrations, was nominally associated with
AIR (β=0.89 [log10 scale], p=0.07, adjusted for age, sex,
percentage body fat and rate of glucose disappearance during
insulin stimulation). The promoter SNP rs193226243 was
also associated with AIR (β=0.92 [log10 scale], adjusted p=
0.02). However, the 3′UTR SNP was not associated with AIR
(adjusted p=0.46).
Association of the eight tag SNPs with maximum BMI
were also analysed (Table 4). SNP rs193226243 had a nom-
inal association with BMI in a combined analyses of 6,797
American Indians (β=0.02 (loge scale), p=0.008, adjusted for
age, sex, birth year and heritage). None of other SNPs was
consistently associated with BMI.
The predictive effect of carbohydrate oxidation rate on devel-
opment of type 2 diabetes We further evaluated the relation-
ship between the rate of insulin-stimulated carbohydrate oxi-
dation and the risk of developing type 2 diabetes in 287 full-
heritage Pima Indians. Of these 287 individuals with NGT
who had measures of carbohydrate oxidation rate during
insulin stimulation at baseline (baseline age 26.4±6.0 years)
and also had follow-up data for development of diabetes
(follow-up time 7.8±8.2 years), 99 (34%) developed type 2
diabetes. Figure 3 shows the Kaplan–Meier survival curve for
time to type 2 diabetes onset with participants categorised as
those with a higher or lower rate of insulin-stimulated carbo-
hydrate oxidation than the mean of 1.63 mg (kg EMBS)−1
min−1. Individuals with a lower rate of insulin-stimulated
carbohydrate oxidation (n=150; carbohydrate oxidation rate
1.35±0.23mg [kg EMBS]−1min−1; age 26.4±5.8 years) had a
shorter period to type 2 diabetes onset, hence a higher risk for
developing type 2 diabetes as compared with those with a
higher rate of carbohydrate oxidation (n=137; carbohydrate
oxidation rate 1.94±0.26 mg [kg EMBS]−1min−1; age 26.5±
6.3 years) (HRR 2.2, 95% CI 1.3, 3.6, p=0.002, adjusted for
age, sex, percentage body fat, AIR and non-oxidative glucose
disposal rate). The same result was observed with individuals
categorised as those with a higher or lower median rate of



















































































Fig. 2 (a) Time course of 24 h energy expenditure in the respiratory
chamber based on genotypes for the 3′UTR SNP chr7:44184184-G/A.
Arrows indicate when meals were provided (B, breakfast; L, lunch; D,
dinner; S, snack); solid line, homozygous GG (n=251); dashed line,
GA+AA (n=22). (b) Components of 24 h energy expenditure based on
genotypes for the 3′UTR SNP. White bar, the thermic effect of food; grey
bar, SPA; black bar, sleeping metabolic rate. ***p<0.001. (c) 24 h
macronutrient oxidation in the respiratory chamber based on genotype
for the 3′UTR SNP. White bar, GG (n=277); black bar, GA+AA (n=23).
Error bar: SD. *p<0.05
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insulin-stimulated carbohydrate oxidation (1.61 mg [kg
EMBS]−1min−1). In a Cox proportional hazards analysis, a
lower than the mean rate of insulin-stimulated non-oxidative
glucose disposal at baseline also predicted a higher risk for
developing type 2 diabetes than a rate above the mean (HRR
2.5, 95% CI 1.4, 4.5, p=0.002, adjusted for age, sex, percent-
age body fat, AIR and glucose oxidation rate; data not shown).
Allelic specific GCK expression To investigate whether the
alleles of the 3′UTR SNP chr7:44184184-G/A differentially
influence gene expression, allelic specific expression of GCK
was assessed in adipose tissue biopsies from individuals het-
erozygous for this SNP. No difference in the allelic expression
of GCK was observed in this tissue (G/A=0.993 vs expected
ratio of 1, p=0.2, data not shown). Since liver and pancreas
Table 3 Associations of eight tag SNPs in GCK with type 2 diabetes and fasting glucose concentrations in American Indians
SNP Risk/Non Full-heritage, type 2 diabetes
(n=3,604)
Mixed-heritage, type 2 diabetes
(n=4,063)




RAF OR (95% CI) p value RAF OR (95% CI) p value OR (95% CI) p value β value p value
rs4607517a
5′-upstream
T/C 0.34 0.97 (0.86, 1.09) 0.616 0.29 1.20 (1.04, 1.38) 0.010 1.07 (0.97, 1.17) 0.158 0.06 8.7×10−7
rs1476891
promoter
A/G 0.10 1.26 (1.04, 1.53) 0.016 0.16 1.08 (0.91, 1.29) 0.380 1.15 (1.02,1.31) 0.029 0.03 0.053
rs193226243
promoter
A/G 0.09 1.11 (0.91, 1.36) 0.316 0.06 0.97 (0.72, 1.30) 0.837 1.07 (0.90, 1.26) 0.445 0.08 0.0003
rs1799831
promoter
T/C 0.94 1.02 (0.79, 1.31) 0.894 0.89 0.82 (0.68, 1.00) 0.056 0.91 (0.77, 1.06) 0.215 0.01 0.476
GCK-G193G
Gly193Gly
C/T 0.01 1.17 (0.68, 2.01) 0.581 0.01 1.98 (0.97, 4.08) 0.061 1.38 (0.86, 2.20) 0.177 0.25 4.3×10−5
rs13306388
3′UTR
C/T 0.74 1.04 (0.91, 1.19) 0.603 0.76 1.04 (0.89, 1.22) 0.605 1.04 (0.94, 1.15) 0.470 0.01 0.516
chr7:44184184
3′UTR
A/G 0.05 1.37 (1.06, 1.78) 0.015 0.03 1.32 (0.97, 1.79) 0.075 1.36 (1.11, 1.65) 0.002 −0.02 0.473
rs55714218
3′UTR
G/- 0.78 1.05 (0.92, 1.20) 0.462 0.71 0.84 (0.73, 0.97) 0.014 0.95 (0.86, 1.05) 0.292 −0.01 0.515
The analysis for ‘combined’ is conducted in full-heritage Pima Indians and mixed-heritage American Indians. The risk allele (given first) for rs4607517
is defined as the observed risk allele in European studies, while for other SNPs it is defined as the allele with a higher risk of diabetes in full-heritage Pima
Indians; ORs are given per copy of this allele. RAF is the frequency of the risk allele. Beta for fasting glucose concentrations represents the effect in
mmol/l per copy of the risk allele. The p values were adjusted for age, sex, birth year and heritage
a Established type 2 diabetes variant in European populations




Full-heritage Pima Indian (n=3,391), mean BMI
(kg/m2)
















β value p value β value p value
rs4607517 T/C 0.34 38.2 37.5 37.2 0.013 0.028 0.29 34.8 35.1 34.7 0.003 0.608 0.008 0.065
rs1476891 A/G 0.10 37.7 36.9 37.6 −0.006 0.512 0.16 34.3 34.4 35.0 −0.002 0.781 −0.005 0.433
rs193226243 A/G 0.09 39.2 37.9 37.4 0.012 0.216 0.06 30.7 36.4 34.6 0.029 0.020 0.020 0.008
rs1799831 T/C 0.94 37.5 36.9 38.1 0.012 0.307 0.89 34.9 34.8 30.4 0.005 0.555 0.009 0.238
GCK-G193G C/T 0.01 38.7 37.4 0.046 0.085 0.01 35.1 34.8 −0.028 0.548 0.020 0.432
rs13306388 C/T 0.74 37.3 37.7 38.2 −0.006 0.342 0.76 34.8 34.7 34.6 −0.002 0.720 −0.005 0.321
Chr7:44184184 A/G 0.05 41.4 37.9 37.4 0.008 0.571 0.03 30.8 36.6 34.7 0.018 0.268 0.012 0.254
rs55714218 G/− 0.78 37.8 37.7 37.1 0.002 0.822 0.71 34.7 34.8 34.7 0.002 0.728 0.003 0.555
BMI is the maximum value observed in the longitudinal study from all examinations after age 15 years. The risk allele is defined as the allele with a
higher risk of diabetes in full-heritage Pima Indians; the regression coefficient (B) represents the effect on the logarithmic scale (loge) per copy of the risk
allele. Mean BMI was unadjusted. The p values were adjusted for age, sex, birth year and heritage
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tissue biopsies from Pima Indians were not available for study,
the allelic specific expression of GCK in these tissues is not
known.
Discussion
GCK is the main glucose-phosphorylating enzyme in the liver
and pancreatic beta cells. It converts glucose to G6P as a first
and rate-limiting step in glycolysis, which plays a part in the
process of glucose oxidation [1–3]. Our study indicates that a
novel variant in the 3′UTR ofGCK, with a risk allele frequen-
cy of 0.05, is associated with a lower rate of glucose oxidation
post-absorptively, during insulin stimulation and after a diet of
mixed consumption, which is in agreement with the role of
GCK in glycolysis. This variant was not associated with non-
oxidative glucose disposal, suggesting that glucose storage
(glycogen synthesis) was not affected. It is known that rare
mutations in GCK occurring in MODY result from a reduced
glucose-stimulated insulin secretion. Although rs193226243
and rs4607517 had borderline associations with AIR, none of
the other common variants were associated with AIR. There-
fore, our data suggest that common variation inGCK predom-
inantly influences glycolysis and the rate of glucose oxidation
in hepatocytes. These data are consistent with the observations
that overexpression of GCK in mouse liver or rat isolated
hepatocytes enhances glucose oxidation [19, 20]. Neverthe-
less, a subtle effect of common GCK variants on beta cell
function cannot be ruled out. Since theGCK variants affect the
threshold for glucose sensing, the effect size and/or sample
size may be too small to render a statistical difference in
insulin secretion. It is also possible that the 25 g intravenous
glucose bolus used in the AIR measurement may be above the
threshold at which GCK exerts its effect, thus limiting a
positive detection.
Hepatic GCK serves as a major component of the hepatic
glucose-sensing system involved in glucose synthesis, break-
down and storage. While glycolysis and glycogen synthesis
pathways are activated during the postprandial state, gluco-
neogenesis and glycogen breakdown are involved in hepatic
glucose production in the post-absorptive state. Our data
indicate that the association of the 3′UTR GCK variant with
the rate of basal hepatic glucose production is likely due to an
association with the rate of basal glucose oxidation. However,
this variant was not associated with hepatic glucose produc-
tion during insulin stimulation, despite previous findings dem-
onstrating that a GCK variant was associated with hepatic
insulin resistance [21].
In addition to its pivotal role in glucose metabolism, a new
role for hepatic GCK in energy metabolism has emerged in
recent studies. Tsukita and co-workers reported that upregu-
lation of hepatic GCK by high-fat diet feeding in mice sup-
presses brown adipose tissue (BAT) thermogenesis via leptin-
mediated neural signals and downregulation of uncoupling
protein-1 [22, 23]. This GCK-mediated liver-to-BAT neuronal
relay system provides a novel mechanism in modulating obe-
sity predisposition in mice. In this study, we report that the
novel 3′UTR variant in GCK had a significant effect on 24 h
energy expenditure through a change in the thermic effect of
food. This effect resulted from a change in the rate of carbo-
hydrate oxidation rather than from any apparent effect on BAT
thermogenesis.
Measures of energy expenditure, thermic effect of food and
substrate oxidation are predictors of weight change. In Pima
Indians, individuals with lower than expected energy expen-
diture are at higher risk for future long-term increases in
weight and fat mass [16]. The thermic effect of food is also
reduced in obese individuals and predicts their future weight
gain [18]. A higher rate of insulin-stimulated carbohydrate
oxidation during a hyperinsulinaemic–euglycaemic clamp
predicts a future weight again [24]. The rate of carbohydrate
oxidation in a respiratory chamber also predicts short-term
changes in body weight [14], but not long-term changes [16].
In the present study, the 3′UTR SNP, associated with
rates of energy expenditure and carbohydrate oxidation,
was not associated with BMI. Nevertheless, this 3′UTR
SNP was associated with risk of type 2 diabetes in
Pima Indians. This most likely results from the effect
on carbohydrate oxidation since we found that a lower
carbohydrate oxidation rate during insulin stimulation
was associated with a higher risk of type 2 diabetes,
independent of age, sex, percentage body fat, AIR and
non-oxidative glucose disposal rate. Thus, while rare
mutations in GCK cause MODY and neonatal diabetes,























Fig. 3 Survival curve for time to type 2 diabetes (T2D) onset in 287 full-
heritage Pima Indians with NGT at baseline. Solid line, carbohydrate
oxidation rate > a mean of 1.63 mg(kg EMBS)−1min−1 (n=137); dashed
line, carbohydrate oxidation rate <1.63 mg(kg EMBS)−1min−1 (n=150).
Data are plotted up to the follow-up time of ∼23 years, and omitted at
longer follow-up time when only 1% of participants were involved. HRR
2.2, 95% CI 1.3, 3.6; **p<0.01
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our data indicate that common variation in GCK with a
modest effect on the rate of carbohydrate oxidation
contributes to risk of type 2 diabetes.
In summary, our study in individuals who had been exten-
sively characterised for metabolic traits provides cohesive
evidence to support a hepatic effect of a novel 3′UTR variant
inGCK on influencing carbohydrate oxidation, energy expen-
diture and type 2 diabetes risk; this is consistent with the role
of GCK in hepatic glycolysis and energy metabolism. How-
ever, our functional analysis of this 3′UTR SNP in adipose
tissue did not support a role in allelic imbalance of GCK
expression in this particular tissue. Interpretation of this neg-
ative result is unclear since this SNP could potentially affect
transcriptional regulation or mRNA stability in a tissue-
specific manner, and we do not have access to liver or pan-
creatic beta cells from Pima individuals. Alternatively, this 3′
UTR SNP might alter GCK translation via an effect on
microRNA binding, or perhaps this SNP is in LD with an
undiscovered functional variant. Future studies in liver or
pancreatic biopsy tissues would clarify some of these possible
mechanisms.
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